Monday, October 7, 2019

03 Third Journal Club: Probiotics Improve Inflammation-Associated Sickness Behavior by Altering Communication between the Peripheral Immune System and the Brain

The purpose of this study and the possible clinical application of this study was very clear. I enjoyed reading this paper, but the results section was quite confusing with a lot of data from different experiments.
 
The study of interaction and the gut was very interesting, and the idea of microbiota in the human gut causing changes in neural activity was intriguing. This study focuses on the effect of orally taken probiotic on the sickness behavioral of mice with liver inflammation; although they used just liver inflammation, the big picture is to help advance the use of probiotics to improve the quality of life for patients with systematic inflammatory disease. One question that I had when I started reading this paper was regarding the reason liver inflammation was chosen for the study; they did mention that they had a previous study related to the periphery-to-brain communication pathway.
 
I noticed that they did multiple assessments and observations to follow up on liver inflammation. In the results section, they stated that they did not see significant effects on bowel permeability, disruption to the gut microbiome, and changes in the inflammation or fibrosis. It was interesting how probiotic consumption had no major effects on the gut system but had significant effects on the neural system.
 
The mechanism of attenuation of sickness behavior in mice with live inflammation that the study stated was the reduction of proinflammatory cytokines – including TNF-alpha, which is the focus of this study. However, the study does not go deep into how the bacteria in VSL#3 reduce the proinflammatory cytokine; I thought it would be interesting to see the detailed mechanism of how the consumption of the probiotic reduces the proinflammatory cytokines.
 
Regarding the behavioral study, this study needed more assessments other than the social investigation. Although they did weight the mice every day, the only behavioral test they ran was the social investigation. I believe this is not enough of test and data for the study as they are trying to prove that the probiotic is attenuating the sickness behavior in the mice with inflammation.
 
In the results section, it was very difficult to follow Table 1. On the other hand, the graphs were very easy to recognize the significant difference between the four groups. It was odd that they never mentioned the number of mice they used for the study in the methodology section but did in the captions for the graphs. Similar to the study from last week, it would have been better if they had a larger subject group; they had 5 to 14 mice per group. Also, it is very unclear which group had how many subjects as they just stated “n = 5-14/group”.
 
Overall, there are parts of the study that can be improved, but the study was very interesting. Although this was my first neurogastroenterology paper and was difficult grasping details, I enjoyed reading this paper.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.